Jason Stienecker, DO
Pulmonary Disease · Lima, OHNPI 1538455720
Payments from drug & device makers
Across 701 payments — averaging $579.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$354K
- Olympus America Inc.$15K
- Merck$12K
- Actelion Pharmaceuticals US, Inc.$9K
- Intuitive Surgical$6K
- AstraZeneca$5K
- plus $6K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 451 | $354,038 |
| Olympus America Inc. | 31 | $14,760 |
| Merck | 19 | $12,289 |
| Actelion Pharmaceuticals US, Inc. | 30 | $8,570 |
| Intuitive Surgical | 24 | $6,229 |
| AstraZeneca | 19 | $4,866 |
| Bayer | 11 | $3,086 |
| Galvanize Therapeutics, Inc | 2 | $615 |
| Regeneron Healthcare Solutions, Inc. | 8 | $462 |
| Boehringer Ingelheim | 22 | $339 |
| GSK | 32 | $294 |
| Healthmyne, Inc. | 1 | $133 |
| Genentech USA, Inc. | 7 | $109 |
| Sunovion Pharmaceuticals Inc. | 8 | $85 |
| Sanofi | 5 | $75 |
| Mylan Specialty L.p. | 5 | $71 |
| Johnson & Johnson(2 entities) | 4 | $47 |
| Grifols USA, LLC | 3 | $47 |
| Philips North America LLC | 3 | $44 |
| Medtronic | 1 | $44 |
| Electromed, Inc. | 3 | $43 |
| Insmed, Inc. | 2 | $26 |
| Shire North American Group Inc | 2 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Vapotherm Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Apria Healthcare LLC | 1 | $12 |
How this compares
$406,420 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Lima
- Marc RovnerLima$127K
- Bruce CorserCincinnati$8.2M
- Edward CordascoColumbus$8M
- Kristin HighlandCleveland$3.2M
- Brian ZenoColumbus$2.9M
- Jean ElwingCincinnati$2.4M
- Roy St JohnColumbus$1.9M
- Nishant GuptaCincinnati$1.5M
- Robert BaughmanCincinnati$1.1M
- Francis McCormackCincinnati$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.